Clinuvel Pharmaceuticals
CUV.AX
#7292
Rank
NZ$0.59 B
Marketcap
$11.80
Share price
-0.27%
Change (1 day)
-27.99%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2024: NZ$56.9 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are NZ$59.01 Million. In 2024 the company made an earning of NZ$56.9 Million, an increase over its 2023 earnings that were of NZ$50.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024NZ$56.9 M12.42%
2023NZ$50.61 M27.77%
2022NZ$39.61 M22.23%
2021NZ$32.41 M114.01%
2020NZ$15.14 M-29.03%
2019NZ$21.33 M32.76%
2018NZ$16.07 M75.24%
2017NZ$9.17 M-332.09%
2016-NZ$3.96 Million-70.52%
2015-NZ$13.41 Million53.56%
2014-NZ$8.73 Million-16.31%
2013-NZ$10.44 Million-37.85%
2012-NZ$16.79 Million-18%
2011-NZ$20.47 Million25.86%
2010-NZ$16.27 Million-21.79%
2009-NZ$20.8 Million-11.73%
2008-NZ$23.56 Million80.71%
2007-NZ$13.04 Million-2.86%
2006-NZ$13.42 Million-4.95%
2005-NZ$14.12 Million60.55%
2004-NZ$8.8 Million97.37%
2003-NZ$4.46 Million50.62%
2002-NZ$2.96 Million121.22%
2001-NZ$1.34 Million254.48%
2000-NZ$0.38 Million